Navigation Links
Otomagnetics Awarded a $2.3M Fast Track NIH/NCI SBIR Contract to Develop a Pediatric Cancer Drug Delivery System to Prevent Hearing Loss From Chemotherapy Regimens
Date:10/12/2017

Information about the technology:

Otomagnetics has invented a magnetic drug delivery system that we intend to develop to enable prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin chemotherapy regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing loss in kids has a dramatic impact on their ability to communicate and learn and is associated with substantial cognitive and speech development deficits. Our drug delivery technology enables topical delivery of otoprotective therapy to the cochlea, and in animal studies has been shown to protect hearing from cisplatin regimens. Topical and non-invasive magnetic delivery of a small dose of otoprotective steroid to the cochlea would have no risk of interrupting the systemic anti-tumor action of chemotherapy, and in some patients could remove limits on administering needed chemo doses due to induced severe hearing loss. Funding support shall be used to progress our delivery system through FDA milestones, so it can reach patients.

Our device acts like a syringe, with the needle replaced by non-invasive magnetic forces that safely and effectively deliver therapy to difficult targets, including to the cochlea.

“We are honored and excited to be working closely with the National Institutes of Health to address a pressing clinical need. There should not have to be a choice between effective chemo and lifelong hearing loss. Our technology has the potential to allow treatment by chemotherapy without the attendant risk of hearing loss.” – Dr. Benjamin Shapiro, President and CEO, Otomagnetics.

About Otomagnetics:

Otomagnetics is developing a non-invasive method to effectively deliver drugs and other therapeutic payloads to hard-to-reach targets in the body, to ear compartments, to the eye, and into the skin.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14778666.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. NetCloud, LLC Awarded Anomaly Detection and Failure Prediction Prime Federal Contract by NASA
2. Adult & Child Health Awarded "Homeless Services Provider of the Year" by Indianapolis Coalition for Homeless Intervention and Prevention
3. Scientists at the Foundation for Applied Molecular Evolution Awarded One of Eight Nationwide Transformative Research Awards - Totaling $3 million
4. David Daggett Awarded “Buddy of the Year”, Highest Honor Given by the Piedmont Down Syndrome Support Network
5. DETECTO Awarded Patient Scales Agreement with Premier Inc.
6. Record $1.5 million NCI NIH grant awarded
7. REBBL® Awarded First-ever NEXTY Gold Award At Natural Products Expo East 2017
8. Reflections Recovery Center in Arizona Awarded The Joint Commission’s Gold Seal of Approval for Residential Addiction Treatment
9. MakroCare awarded a large cancer registry program by a promising US biotech company
10. EXOUS Bodygear 65cm Exercise Awarded Amazon's Choice Birthing Ball in the exercise ball category
11. DSS, Inc. Awarded Dialysis Electronic Medical Record Software and Maintenance Electronic Health Record (EHR) with the VA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/13/2017)... --  OrthoAtlanta has been named the official orthopedic and ... for the 2018 College Football Playoff (CFP) National Championship to ... in Atlanta, Georgia . OrthoAtlanta is proud ... participating in many activities leading up to, and including the ... ...
Breaking Medicine Technology: